Republican Sen. Katie Britt of Alabama is sounding the alarm about “the slow disbursement rate” of National Institutes of Health funding included in the March spending bill signed by President Donald Trump.
The EPA is trying to revoke its authority to regulate greenhouse gases by challenging a key scientific finding, despite new evidence reinforcing its validity. Experts warn this could undermine climate policy and face legal backlash.
Several wealthy universities are walking back construction plans due to financial uncertainty driven by the Trump administration, particularly around federal research funding.
Universities are offering temporary relief to researchers whose projects have been disrupted by federal funding cuts. But it won’t help in the long term, and experts say industry and philanthropy are in no position to make up for the losses.
A new study warns that the Trump administration’s reductions in federal funding for scientific research and development could have serious long-term economic consequences.
Uncertainty over federal funding for bioscience programs is endangering U.S. leadership in the field, which could affect drug development and the nation’s competitiveness more widely.
National Institutes of Health grants generated almost $95 billion in economic activity nationwide according to a just-released report by United for Medical Research.
It’s a no-brainer that American public policy should aim to significantly increase both government and private-sector R&D investment to boost innovation-driven productivity and economic growth.
